Morwenna T Muir (Morwenna Muir)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Top Venues

Cancer research

Science advances

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Callam T Davidson, Eileen Miller, Morwenna T Muir, John C Dawson, Martin Lee, Stuart Aitken, Alan Serrels, Scott P Webster, Natalie Z M Homer, Ruth Andrew, Valerie G Brunton, Patrick W F Hadoke, Brian R Walker
11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis. PloS one 18 (3) (2023)
Callam T Davidson, Eileen Miller, Morwenna T Muir, John C Dawson, Martin Lee, Stuart Aitken, Alan Serrels, Scott P Webster, Natalie Z M Homer, Ruth Andrew, Valerie G Brunton, Patrick W F Hadoke, Brian R Walker
11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis. PloS one 18 (3) (2023)
Callam T Davidson, Eileen Miller, Morwenna T Muir, John C Dawson, Martin Lee, Stuart Aitken, Alan Serrels, Scott P Webster, Natalie Z M Homer, Ruth Andrew, Valerie G Brunton, Patrick W F Hadoke, Brian R Walker
11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis. PloS one 18 (3) (2023)
Callam T Davidson, Eileen Miller, Morwenna T Muir, John C Dawson, Martin Lee, Stuart Aitken, Alan Serrels, Scott P Webster, Natalie Z M Homer, Ruth Andrew, Valerie G Brunton, Patrick W F Hadoke, Brian R Walker
11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis. PloS one 18 (3) (2023)
Henry Beetham, Billie G C Griffith, Olga Murina, Alexander E P Loftus, David A Parry, Carolin Temps, Jayne Culley, Morwenna T Muir, Asier Unciti-Broceta, Andrew H Sims, Adam Byron, Valerie G Brunton
Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors. Cancer research 82 (4) (2022)
Carolin Temps, Daniel Lietha, Emily R Webb, Xue-Feng Li, John C Dawson, Morwenna T Muir, Kenneth G Macleod, Teresa Valero, Alison F Munro, Rafael Contreras-Montoya, Juan Román Luque-Ortega, Craig Fraser, Henry Beetham, Christina Schoenherr, Maria Lopalco, Mark J Arends, Margaret C Frame, Bin-Zhi Qian, Valerie G Brunton, Neil O Carragher, Asier Unciti-Broceta
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability. Cancer research 81 (21) (2021)
John C Dawson, Bryan Serrels, Adam Byron, Morwenna T Muir, Ashraff Makda, Amaya García-Muñoz, Alex von Kriegsheim, Daniel Lietha, Neil O Carragher, Margaret C Frame
A Synergistic Anticancer FAK and HDAC Inhibitor Combination Discovered by a Novel Chemical-Genetic High-Content Phenotypic Screen. Molecular cancer therapeutics 19 (2) (2019)
Priya Hari, Fraser R Millar, Núria Tarrats, Jodie Birch, Andrea Quintanilla, Curtis J Rink, Irene Fernández-Duran, Morwenna T Muir, Andrew J Finch, Valerie G Brunton, João F Passos, Jennifer P Morton, Luke Boulter, Juan Carlos Acosta
The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype. Science advances 5 (6) (2019)